| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $262.2M | — | +20.4% |
| R&D Expense | $49.6M | — | +13.4% |
| SG&A Expense | $24.3M | — | +4.2% |
| Operating Income | $50.7M | — | +50.2% |
| Pre-tax Income | $53.1M | — | +44.3% |
| Income Tax | $10.7M | — | +97.4% |
| Net Income | $42.4M | — | +35.2% |
| EPS (Basic) | $1.19 | — | +38.4% |
| EPS (Diluted) | $1.18 | — | +37.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $147.4M | +37.8% | +158.9% |
| Accounts Receivable | $44.0M | +19.2% | +60.1% |
| Current Assets | $254.9M | -27.8% | -6.3% |
| Total Assets | $580.6M | -15.7% | +2.8% |
| Current Liabilities | $72.4M | -32.3% | +23.5% |
| Total Liabilities | $110.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $34.3M | — | -10.8% |
| Capital Expenditures | $231K | — | +0.4% |
| Investing Cash Flow | $138.3M | — | +71.2% |
| Financing Cash Flow | -$132.2M | — | -26.1% |
| Free Cash Flow | $34.1M | — | -10.9% |
| +7.5% |
| Stockholders' Equity | $470.2M | -13.3% | +1.8% |